Vital Capital Portfolio

Market Analysis According to JLL, triple-net rental growth has benefited from strong occupancy and limits on new supply. Average medical office net rents have grown steadily from $18.28 per square foot in 2012 to $21.51 in early 2020.

Medical office occupancy across approximately 1.5 billion square feet in the United States has fluctuated in a remarkably narrow band, between 91.4%and 92.6% between the depths of the Great Financial Crisis and today. With national office occupancy ranging from 82.1 percent to 85.8 percent during the same time frame, the appeal of medical office to investors seeking stable occupancy is easily understood.

Interest in medical office has continued at a rapid pace ever since the Great Financial Crisis put a spotlight on the durable investment qualities of this property class. As investor awareness grew, typical sales volume per year more than doubled, from $6.8 billion in 2012 to $14.7 billion by 2017.

The two groups driving care demand—millennial heads of households and the growing 65+ demographic—value preventive and personalized care to take advantage of the ever-increasing possibility of a long, healthy lifetime.

Millennials in particular desire a full complement of lifestyle components to mutually reinforce the concept of the wellness-centric lifestyle. Additionally, COVID-19 has rendered preexisting condition seven more dangerous, further enhancing the value of wellness and preventive care.

The properties included in this portfolio represent the assets that Vital Capital Properties intends to buy upon successful capital raise. In case one or more of the properties become unavailable during the raise, Vital Capital Properties is responsible for finding an asset with comparable parameters (size, income,location, return, etc).

Bravo Capital Advisors is a New York based asset management company that partnered with Vital Capital Properties to deliver top portfolio performance to our investors. Persistent personal commitment to daily project work and a focus on the long-term success of clients are the key principals of their business. Their team has over 12 years of experience in real estate.

Vital Capital Properties is using a leading escrow provider. Having an escrow account allows us to ensure that an independent mediator oversees the transaction and keeps investors’ money safe until the sufficient amount of capital is raised. Please refer to the Purchase Agreement for more details.

REINNO is the digital share issuer (tokenization provider). It takes care of the technical part of this offering, including token (digital shares) issuance and distribution. REINNO also provides a marketplace where investors can buy digital shares of Vital Capital Properties. They are exclusively available at app.reinno.io

The contents herein are not to be construed as legal, business, or tax advice, and each prospective investor should consult its own attorney, business advisor, and tax advisor as to legal, business and tax advice. Investors should consult their investment advisors before participating in the offering. In considering any performance information contained herein, prospective investors should bare in mind that past and projected performance is not necessarily indicative of future results, and there can be no assurance that the Company will achieve comparable results or that target returns, if any, will be met. This Presentation contains projections and other forward‐looking statements that involve risks and uncertainties. Although we believe such projections and forward‐looking statements are based on reasonable assumptions, there can be no assurance that these expectations will prove correct and the actual results the Company achieves may differ materially from such projections and forward‐looking statements. These projections and forward‐looking statements are based on current assumptions, and the Company assumes no obligation to update this information. These assumptions may be affected by a number of risk factors, many of which are beyond the Company’s control, and, accordingly, there can be no assurance that any of these assumptions will be realized. This presentation and the information contained herein is confidential. By acceptance hereof, you (and your employees, agents, and affiliates) agree not to release or reveal it (or any of the information contained herein) to any third party and, upon request from the Company, will return or destroy such information and all copies thereof.Any reproduction or re‐transmission of this information, in whole or in part,without specific prior written consent of the Company is prohibited.